Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2015-12-23

Clinical Trial Update: Tobacco Dependence in Breast Cancer Patients Trial of Varenicline (Chantix)

View source ↗

Summary

A clinical trial evaluating tobacco dependence in breast cancer patients using varenicline (Chantix) has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CHANTIX (varenicline tartrate)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Breast Cancer, Tobacco Dependence | Status: TERMINATED